PASSAGE BIO Trademark

Trademark Overview


On Friday, January 17, 2020, a trademark application was filed for PASSAGE BIO with the United States Patent and Trademark Office. The USPTO has given the PASSAGE BIO trademark a serial number of 88764198. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by Passage Bio, Inc.. The PASSAGE BIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; medicines for human purposes, namely, for treating genetically based diseases and disorders; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy for rare monogenic central nervous system diseases; pharmaceutical compositions containing adeno-associated virus (AAV) vectors for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders

Pharmaceutical research and development; clinical research in the field of genetic medicine, gene therapy and regenerative medicines; testing, inspection, research, or development of pharmaceutical preparations and substances for genetic medicine, gene therapy and regenerative medicines; biological information analysis, namely, genetic testing for medical research purposes; scientific research in the fields of medicine, genetics, genetic medicines, regenerative medicines, gene therapy, biologics, and central nervous system diseases; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; medical and scientific research, namely, conducting clinical trials for others; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease
passage bio

General Information


Serial Number88764198
Word MarkPASSAGE BIO
Filing DateFriday, January 17, 2020
Status700 - REGISTERED
Status DateTuesday, August 22, 2023
Registration Number7145870
Registration DateTuesday, August 22, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; medicines for human purposes, namely, for treating genetically based diseases and disorders; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy for rare monogenic central nervous system diseases; pharmaceutical compositions containing adeno-associated virus (AAV) vectors for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders
Disclaimer with Predetermined Text"BIO"
Goods and ServicesPharmaceutical research and development; clinical research in the field of genetic medicine, gene therapy and regenerative medicines; testing, inspection, research, or development of pharmaceutical preparations and substances for genetic medicine, gene therapy and regenerative medicines; biological information analysis, namely, genetic testing for medical research purposes; scientific research in the fields of medicine, genetics, genetic medicines, regenerative medicines, gene therapy, biologics, and central nervous system diseases; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; medical and scientific research, namely, conducting clinical trials for others; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 24, 2020
Primary Code005
First Use Anywhere DateMonday, March 29, 2021
First Use In Commerce DateMonday, March 29, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 24, 2020
Primary Code042
First Use Anywhere DateThursday, April 1, 2021
First Use In Commerce DateThursday, April 1, 2021

Trademark Owner History


Party NamePassage Bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19103

Party NamePassage Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19103

Party NamePassage Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19103

Trademark Events


Event DateEvent Description
Tuesday, August 22, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 22, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 18, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 17, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 17, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, July 14, 2023USE AMENDMENT FILED
Friday, July 14, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, January 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 27, 2023SOU EXTENSION 5 GRANTED
Thursday, January 12, 2023SOU EXTENSION 5 FILED
Thursday, January 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 12, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 6, 2022SOU EXTENSION 4 GRANTED
Wednesday, July 6, 2022SOU EXTENSION 4 FILED
Wednesday, July 6, 2022SOU TEAS EXTENSION RECEIVED
Saturday, January 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 13, 2022SOU EXTENSION 3 GRANTED
Thursday, January 13, 2022SOU EXTENSION 3 FILED
Thursday, January 13, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 6, 2021SOU EXTENSION 2 GRANTED
Tuesday, July 6, 2021SOU EXTENSION 2 FILED
Tuesday, July 6, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, January 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 4, 2021SOU EXTENSION 1 GRANTED
Monday, January 4, 2021SOU EXTENSION 1 FILED
Monday, January 4, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 19, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 13, 2020ASSIGNED TO LIE
Monday, April 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 6, 2020EXAMINER'S AMENDMENT ENTERED
Monday, April 6, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 6, 2020EXAMINERS AMENDMENT E-MAILED
Monday, April 6, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, April 6, 2020ASSIGNED TO EXAMINER
Friday, January 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 21, 2020NEW APPLICATION ENTERED